The sympathetic nervous system is controlled by transient receptor potential vanilloid 1 in the regulation of body temperature

FASEB J. 2015 Oct;29(10):4285-98. doi: 10.1096/fj.15-272526. Epub 2015 Jul 1.

Abstract

Transient receptor potential vanilloid 1 (TRPV1) is involved in sensory nerve nociceptive signaling. Recently, it has been discovered that TRPV1 receptors also regulate basal body temperature in multiple species from mice to humans. In the present study, we investigated whether TRPV1 modulates basal sympathetic nervous system (SNS) activity. C57BL6/J wild-type (WT) mice and TRPV1 knockout (KO) mice were implanted with radiotelemetry probes for measurement of core body temperature. AMG9810 (50 mg/kg) or vehicle (2% DMSO/5% Tween 80/10 ml/kg saline) was injected intraperitoneally. Adrenoceptor antagonists or vehicle (5 ml/kg saline) was injected subcutaneously. In WT mice, the TRPV1 antagonist, AMG9810, caused significant hyperthermia, associated with increased noradrenaline concentrations in brown adipose tissue. The hyperthermia was significantly attenuated by the β-adrenoceptor antagonist propranolol, the mixed α-/β-adrenoceptor antagonist labetalol, and the α1-adrenoceptor antagonist prazosin. TRPV1 KO mice have a normal basal body temperature, indicative of developmental compensation. d-Amphetamine (potent sympathomimetic) caused hyperthermia in WT mice, which was reduced in TRPV1 KO mice, suggesting a decreased sympathetic drive in KOs. This study provides new evidence that TRPV1 controls thermoregulation upstream of the SNS, providing a potential therapeutic target for sympathetic hyperactivity thermoregulatory disorders.

Keywords: TRPV1; brown adipose tissue; thermogenesis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acrylamides / administration & dosage
  • Acrylamides / pharmacology
  • Adrenergic alpha-1 Receptor Antagonists / administration & dosage
  • Adrenergic alpha-1 Receptor Antagonists / pharmacology
  • Adrenergic beta-Antagonists / administration & dosage
  • Adrenergic beta-Antagonists / pharmacology
  • Animals
  • Body Temperature / genetics
  • Body Temperature / physiology*
  • Body Temperature Regulation / genetics
  • Body Temperature Regulation / physiology*
  • Bridged Bicyclo Compounds, Heterocyclic / administration & dosage
  • Bridged Bicyclo Compounds, Heterocyclic / pharmacology
  • Fever / genetics
  • Fever / physiopathology
  • Humans
  • Injections, Intraperitoneal
  • Injections, Subcutaneous
  • Labetalol / administration & dosage
  • Labetalol / pharmacology
  • Male
  • Mice, 129 Strain
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Prazosin / administration & dosage
  • Prazosin / pharmacology
  • Propranolol / administration & dosage
  • Propranolol / pharmacology
  • Receptors, Adrenergic, alpha-1 / physiology
  • Receptors, Adrenergic, beta / physiology
  • Sympathetic Nervous System / metabolism
  • Sympathetic Nervous System / physiology*
  • TRPV Cation Channels / antagonists & inhibitors
  • TRPV Cation Channels / genetics
  • TRPV Cation Channels / physiology*
  • Telemetry / methods

Substances

  • 3-(4-t-butylphenyl)-N-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide
  • Acrylamides
  • Adrenergic alpha-1 Receptor Antagonists
  • Adrenergic beta-Antagonists
  • Bridged Bicyclo Compounds, Heterocyclic
  • Receptors, Adrenergic, alpha-1
  • Receptors, Adrenergic, beta
  • TRPV Cation Channels
  • TRPV1 protein, mouse
  • Propranolol
  • Labetalol
  • Prazosin